[Lupus Foundation of America 13th International Congress on Systemic Lupus Erythematosus (LUPUS 2019), San Francisco, California, USA, April 5â8, 2019, Abstract Presentations - ()] Abstracts - 32â Safety, pharmacokinetics and pharmacodynamics of BI 705564, a covalent inhibitor of brutons tyrosine kinase in phase 1 clinical trials in healthy volunteers
Litzenburger, Tobias, Müller, Fabian, Schultz, Armin, Klein, Elliott, Ramanujam, Meera, Wu, Jing, Wiebe, Sabrina, Benediktus, Ewald, Hui, Jianan, Li, Xiujiang, Flack, Mary, Padula, Steven J, VisvanatYear:
2019
DOI:
10.1136/lupus-2019-lsm.32
File:
PDF, 68 KB
2019